(D-His2)-Leuprolide Trifluoroacetic Acid Salt is a peptide-based compound used as an active pharmaceutical ingredient in pharmaceutical manufacturing. It is a modified form of leuprolide, featuring a D-histidine substitution at position 2, and is supplied as a trifluoroacetic acid salt.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 112642-11-2
(+/-)-Prasugrel-d3 (acetate-d3)
active pharmaceutical ingredient
1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid--hydrogen chloride (1/1)
active pharmaceutical ingredient
Ropivacaine hydrochloride, (R)-
active pharmaceutical ingredient
Letrozole
active pharmaceutical ingredient
(Des-Gly10,D-Tyr5,D-Leu6,Pro-NHEt9)-LHRH
n.a
(des-gly10,d-leu6,d-leu7,pro-nhet9)-lhrh trifluoroacetate salt
Active pharmaceutical ingredient
(2S)-N-((2R)-1-(((2S)-1-(((2R)-1-(((2S)-1-(((2R)-1-(((2S)-1-(((2S)-5-(diaminomethylideneamino)-1-((2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl)-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl)amino)-3-hydroxy-1-oxopropan-2-yl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl)-5-oxopyrrolidine-2-carboxamide
Pharmaceutical raw material for therapeutic peptide
(Des-Gly10,D-Trp3,D-Leu6,Pro-NHEt9)-LHRH Trifluoroacetate
LHRH analog active pharmaceutical ingredient
(2S)-N-[(2R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
GFIJNRVAKGFPGQ-JFMQHNAUSA-N
CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6